Deferred Tax Assets, Valuation Allowance of Universe Pharmaceuticals INC from 30 Sep 2023 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Universe Pharmaceuticals INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2023 to 30 Sep 2025.
Universe Pharmaceuticals INC Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $2,167,162,000, a 1.4% decline year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Universe Pharmaceuticals INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$2,167,162,000	-$31,314,000	-1.4%	30 Sep 2025	20-F	29 Jan 2026	2025	FY
Q3 2024	$2,198,476,000	+$682,968,000	+45%	30 Sep 2024	20-F	29 Jan 2026	2025	FY
Q3 2023	$1,515,508,000			30 Sep 2023	20-F	29 Jan 2026	2025	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.